Regulation of temozolomide resistance in glioma cells via the RIP2/NF‐κB/MGMT pathway

por Hu, Yu‐Hua, Jiao, Bao‐Hua, Wang, Cheng‐Ye, Wu, Jian‐Liang
Publicado 2021

Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance

por Wang, Xiao‐liang, Jiao, Bao‐hua, Wu, Jian‐liang, Yang, Jian‐kai, Hu, Yu‐hua, Cui, Kai
Publicado 2022

Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410

por Sun, Wei-Li, Kang, Tian, Wang, Yuan-Yu, Sun, Jian-Ping, Li, Chen, Liu, Hong-Jiang, Yang, Yue, Jiao, Bao-Hua
Publicado 2019

DNM3, p65 and p53 from exosomes represent potential clinical diagnosis markers for glioblastoma multiforme

por Yang, Jian-kai, Song, Jian, Huo, Hao-ran, Zhao, Yin-long, Zhang, Guang-yu, Zhao, Zong-mao, Sun, Guo-zhu, Jiao, Bao-hua
Publicado 2017

miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling

por Wang, Shan-shan, Feng, Lu, Hu, Bao-guang, Lu, Ying-fei, Wang, Wei-mao, Guo, Wei, Suen, Chun-wai, Jiao, Bao-hua, Pang, Jian-xin, Fu, Wei-ming, Zhang, Jin-fang
Publicado 2017